New Report "Medical Biotechnology in Germany 2019" published

June 26, 2019 New Report "Medical Biotechnology in Germany 2019" published

Biopharmaceuticals set a new record: there were 38 approvals in 2018, as many as in the previous two years combined.

In his role as chairman of vfa bio, Dr. Frank Mathias presented the industry report "Medical Biotechnology in Germany 2019" by Boston Consulting Group and vfa bio. This year the report focuses on autoimmune diseases, currently the market segment with the highest turnover for biopharmaceuticals.

You can download the full report here (German only, English abstract available).

Contact Person:
Rentschler Biopharma SE
Dr. Cora Kaiser
Senior Director Corporate Communication
communications@rentschler-biopharma.com